Synvista Therapeutics, Inc. (SYNI)
OTCMKTS
· Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Dec 30, 2025
Synvista Therapeutics Revenue
Synvista Therapeutics had revenue of $772.00 in the quarter ending September 30, 2008, a decrease of -27.58%. This brings the company's revenue in the last twelve months to $54.73K, down -51.63% year-over-year. In the year 2007, Synvista Therapeutics had annual revenue of $51.07K, down -17.73%.
Revenue (ttm)
54.73K
Revenue Growth
-51.63%
P/S Ratio
0.00
Revenue / Employee
6.08K
Employees
9
Market Cap
3.00
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2007 | 51.07K | -11.00K | -17.73% |
| Dec 31, 2006 | 62.07K | -37.93K | -37.93% |
| Dec 31, 2005 | 100.00K | -51.82K | -34.13% |
| Dec 31, 2004 | 151.82K | - | - |
| Dec 31, 2003 | - | - | - |
| Dec 31, 2002 | Pro | Pro | Pro |
| Dec 31, 2001 | Pro | Pro | Pro |
| Dec 31, 2000 | Pro | Pro | Pro |
| Dec 31, 1999 | Pro | Pro | Pro |
| Dec 31, 1998 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Veradigm | 588.02M |
| Glass House Brands | 196.17M |
| Elite Pharmaceuticals | 140.12M |
| GlobeImmune | 6.21M |
| Neptune Wellness Solutions | 39.11M |
| Acusphere | 2.68M |
| Biostar Pharmaceuticals | 317.79K |
| BC Craft Supply | 49.09K |